Predictive Oncology Inc.
POAI
Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States. The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment offers clinical testing services comprising tumor drug response testing and genomic profiling tests; and contract research sā¦ read more
Healthcare
Medical Instruments & Supplies
15 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$5.95
Price0.00%
$0.00
1Y
Price
Market Cap
$4.320m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-2144036.7%
EBITDA Margin-2145078.4%
Net Profit Margin-45682.9%
Free Cash Flow MarginRevenue
$728.200k
-55.2%
1y CAGR-15.8%
3y CAGR-10.3%
5y CAGREarnings
-$84.335m
-591.2%
1y CAGR-177.6%
3y CAGR-140.9%
5y CAGREPS
-$108.22
-4731.2%
1y CAGR-1548.5%
3y CAGR-1160.6%
5y CAGRBook Value
-$77.428m
$3.137m
Assets$80.565m
Liabilities$1.704m
DebtDebt to Assets
54.3%
-
Debt to EBITDAFree Cash Flow
-$8.776m
+26.6%
1y CAGR+11.1%
3y CAGR+8.9%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company